Skip to main content
VRXA
NASDAQ Life Sciences

Veraxa Biotech Details BiTAC Pipeline Progress, Targets Lead Candidate VXA-102 for IND/CTA Readiness by Early 2028

Tom Rudovsky · Reported by FinanceWire
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$2.105
Mkt Cap
$66.571M
52W Low
$1.7
52W High
$27.36
52W Position info
24% above low
Off High info
92% below high
Rel. Volume info
3.8× avg
Market data snapshot near publication time

VRXA sits 24% above its 52-week low of $1.7 on elevated volume (3.8× avg).

Summary

Veraxa Biotech provided a corporate and pipeline update, detailing progress on its proprietary BiTAC platform. The company's pipeline now includes four BiTAC-based T-cell engager programs and two bispecific ADC programs, alongside two non-BiTAC assets available for partnering. This follows the company's recent de-SPAC transaction in June and a June 18th 6-K filing which announced successful in vitro proof-of-concept for its BiTAC-ADC platform. Veraxa aims to advance its lead BiTAC-TCE candidate, VXA-102, to IND/CTA readiness by early 2028, and plans to monetize non-BiTAC programs to fund its core BiTAC portfolio. The progress of VXA-102 towards IND/CTA readiness by early 2028 will be a key milestone.

At the time of this announcement, VRXA was trading at $2.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $66.6M. The 52-week trading range was $1.70 to $27.36. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: FinanceWire.


Price Chart

Share this article

Copied!

VRXA - Latest Insights

VRXA
Oct 13, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $0.950 info
Change: -$0.280 (-23%) info
Market Cap: $140.346M info
VRXA
Aug 10, 2026, 5:20 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.83
Real-time Price: $0.950 info
Change: -$0.880 (-48%) info
Market Cap: $140.346M info
VRXA
Jul 31, 2026, 5:13 PM EDT
Filing Type: F-1
Importance Score:
8
Price at Filing: $1.82
Real-time Price: $0.950 info
Change: -$0.870 (-48%) info
Market Cap: $140.346M info
VRXA
Jul 31, 2026, 5:13 PM EDT
Filing Type: F-1
Importance Score:
7
Price at Filing: $1.82
Real-time Price: $0.950 info
Change: -$0.870 (-48%) info
Market Cap: $140.346M info
VRXA
Jul 27, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.97
Real-time Price: $0.950 info
Change: -$1.02 (-52%) info
Market Cap: $140.346M info